Edwards Lifesciences (EW) Gets Favorable FDA Panel Vote for SAPIEN via Transfemoral, Transapical Delivery
Go back to Edwards Lifesciences (EW) Gets Favorable FDA Panel Vote for SAPIEN via Transfemoral, Transapical Delivery| Edwards Lifesciences (NYSE: EW) | Delayed: 92.30 +1.32 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.98 | 52 Week High | $166.87 | |||
| Open | $91.47 | 52 Week Low | $72.20 | |||
| Day High | $93.25 | P/E | 26.83 | |||
| Day Low | $91.27 | EPS | $3.44 | |||
| Volume | 1,366,486 | |||||
